RU2011149421A - PHARMACEUTICAL COMPOSITION FOR INCREASING PHYSICAL PERFORMANCE - Google Patents

PHARMACEUTICAL COMPOSITION FOR INCREASING PHYSICAL PERFORMANCE Download PDF

Info

Publication number
RU2011149421A
RU2011149421A RU2011149421/15A RU2011149421A RU2011149421A RU 2011149421 A RU2011149421 A RU 2011149421A RU 2011149421/15 A RU2011149421/15 A RU 2011149421/15A RU 2011149421 A RU2011149421 A RU 2011149421A RU 2011149421 A RU2011149421 A RU 2011149421A
Authority
RU
Russia
Prior art keywords
physical performance
increasing physical
pharmaceutical composition
metaprot
mildronate
Prior art date
Application number
RU2011149421/15A
Other languages
Russian (ru)
Other versions
RU2487717C1 (en
Inventor
Сергей Иванович Баулин
Светлана Михайловна Рогачева
Снежана Викторовна Афанасьева
Original Assignee
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) filed Critical Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.)
Priority to RU2011149421/15A priority Critical patent/RU2487717C1/en
Publication of RU2011149421A publication Critical patent/RU2011149421A/en
Application granted granted Critical
Publication of RU2487717C1 publication Critical patent/RU2487717C1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ повышения физической работоспособности на основе милдроната, отличающийся тем, что он дополнительно содержит аспаркам и метапрот в следующем количественном соотношении, мг/кг:причем однократный прием препаратов должен осуществляться за 1-1,5 ч до физической нагрузки.A method of increasing physical performance based on mildronate, characterized in that it additionally contains aspartame and metaprot in the following quantitative ratio, mg / kg: moreover, a single dose of drugs should be administered 1-1.5 hours before exercise.

Claims (1)

Способ повышения физической работоспособности на основе милдроната, отличающийся тем, что он дополнительно содержит аспаркам и метапрот в следующем количественном соотношении, мг/кг:A method of increasing physical performance based on mildronate, characterized in that it additionally contains aspartame and metaprot in the following quantitative ratio, mg / kg: МилдронатMildronate 10,710.7 АспаркамAsparkam 5,05,0 МетапротMetaprot 14,3,14.3,
причем однократный прием препаратов должен осуществляться за 1-1,5 ч до физической нагрузки. moreover, a single dose of drugs should be carried out 1-1.5 hours before exercise.
RU2011149421/15A 2011-12-05 2011-12-05 Method of increasing performance capability RU2487717C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011149421/15A RU2487717C1 (en) 2011-12-05 2011-12-05 Method of increasing performance capability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011149421/15A RU2487717C1 (en) 2011-12-05 2011-12-05 Method of increasing performance capability

Publications (2)

Publication Number Publication Date
RU2011149421A true RU2011149421A (en) 2013-06-10
RU2487717C1 RU2487717C1 (en) 2013-07-20

Family

ID=48784548

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011149421/15A RU2487717C1 (en) 2011-12-05 2011-12-05 Method of increasing performance capability

Country Status (1)

Country Link
RU (1) RU2487717C1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135203C1 (en) * 1999-01-26 1999-08-27 Агафонов Александр Викторович Agent showing adaptogenic effect
RU2174003C1 (en) * 2000-04-17 2001-09-27 Зарубин Александр Андреевич Pharmaceutical curative composition, method of curative and curative- prophylactic use of thereof
RU2189243C1 (en) * 2001-08-07 2002-09-20 ЗАО НПП "Фитопродукт" Compositions "ginrosin" showing general tonic and adaptogenic effect
RU2005125660A (en) * 2005-08-05 2007-02-20 Денис В чеславович Лисицын (RU) PHARMACEUTICAL COMPOSITION 3- (2,2,2-TRIMETHYLHYDRAZINY) PROPIONATE DIHYDRATE (MILDRONATE) AND SUITIC ACID SALTS

Also Published As

Publication number Publication date
RU2487717C1 (en) 2013-07-20

Similar Documents

Publication Publication Date Title
CY1119798T1 (en) FORM IV IV Hydrochloride Ibabradine
FR2983409B1 (en) COMPRESSOR CAPABLE OF COMBATTING INJECTION MISTAKE
EA201490760A1 (en) R (+) - N-METHYLPROPARGILAMINOINDAN
MX356789B (en) Prolonged-release diphenidol composition.
RU2011110649A (en) SAMARI-CONTAINING SPIN-GLASS MAGNETIC MATERIAL
EA201190282A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING TAMSULUS
RU2011149421A (en) PHARMACEUTICAL COMPOSITION FOR INCREASING PHYSICAL PERFORMANCE
RU2009122296A (en) IMMUNOMETABOLIC ANTHELMINTIC DRUG
RU2015157534A (en) DRUG FOR TREATMENT OF BONE NOSES, HEADACHES AND PAINS IN THE HEART
RU2011122360A (en) COMPOSITION FOR PREVENTION AND TREATMENT OF PNEUMONIA PIGS
RU2010127706A (en) ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
EA201500368A1 (en) PHARMACEUTICAL COMPOSITION OF 1-ADAMANTYLETHYLOXY-3-MORFOLIN-2-PROPANOL OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR TREATING CARDIOVASCULAR PATHOLOGY
EA201500367A1 (en) PHARMACEUTICAL COMPOSITION OF 1-ADAMANTYLETHYLOXY-3-MORFOLINO-2-PROPANOLAL OR ITS PHARMACEUTICALLY-ACCEPTABLE SALTS FOR THE TREATMENT OF CEREBROVASCULAR PATHOLOGY AND NEURODYGENIRHYIALLYAHI IMPERSING INHCHES OF ANIMAL IMPERSING ANIMAL IMPERSHIPS AND NIRODYGENAIRS OF INTRACTING CEREBROVASCULAR PATHOLOGY AND NEURODYGENIRTHILE IMPERSING INCHILEAUTING IMPING ITURING INHRECTING PATHOLOGY
RU2012122945A (en) ANALGETIC MEANS
RU2013143524A (en) PHARMACEUTICAL COMPOSITION HAVING ANTIVYPOXIC, NEUROPROTECTOR AND ANTIMNESTIC ACTIVITY AND INCREASING PHYSICAL OPERATION
RU2013157796A (en) PHARMACEUTICAL COMPOSITION BASED ON MOXIFLOXACIN
RU2009105933A (en) ANTI-INFLAMMATORY MEDICINE
RU2013121820A (en) COMBINED MEDICINE FOR THE ELIMINATION OF SYMPTOMS AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA
RU2013130140A (en) DRUG FOR TREATMENT OF NECROBACTERIOSIS OF NORTHERN DEER
RU2602742C3 (en) PHARMACEUTICAL COMPOSITION OF N-(6-PHENYLHEXANOYL)GLYCYL-L-TRYPTOPHAN AMIDE, MADE IN SOLID DOSAGE FORM
RU2012105183A (en) PHARMACEUTICAL COMPOSITION FOR PREVENTION OF THE MITOMYCIN-O PROLIFERATIVE CELL REACTION
RU2011132265A (en) PHARMACEUTICAL COMPOSITION (OPTIONS) FOR THE TREATMENT OF DISEASES OF THE musculoskeletal system
RU2013141484A (en) BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOPHERON-1
RU2013131611A (en) MEANS FOR TREATMENT OF ENTERITIS IN ANIMALS
PH12019501607A1 (en) Tapentadol nasal composition

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20171206